accountBy Vivian Ni Late last month, US-based SciClone Pharmaceuticals Inc. (NASDAQ: SCLN) announced it has completed an acquisition of China-based NovaMed
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to SciClone acquires Novamed
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account